会員登録
ログイン
【4931】新日本製薬
ライフスタイルの中で欠かせない化粧品、医薬品、健康食品を取り扱う
類似企業：
【業界1位】
花王
【業界1位】
花王
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
| 決算期 | 日付 | 予・実 | 売上高 (百万円) |
対前回 | 修正率 | 修正率 | 営業利益 (百万円) |
対前回 | 修正率 | 修正率 | 経常利益 (百万円) |
対前回 | 修正率 | 修正率 | 当期利益 (百万円) |
対前回 | 修正率 | 修正率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025.09 | 2024/11/12 | 当初予 | 42,000 | - | - | - | 4,500 | - | - | - | 4,520 | - | - | - | 3,100 | - | - | - |
| 2024.09 | 2024/11/12 | 実 | 40,043 | ↑ | +0.1% | +0.1% | 4,176 | ↑ | +4.4% | +4.4% | 4,103 | ↑ | +3.1% | +3.1% | 2,795 | ↑ | +8.3% | +8.3% |
| 2024.09 | 2024/08/06 | Q3予 | 40,000 | → | 0.0% | 0.0% | 4,000 | → | 0.0% | 0.0% | 3,980 | → | 0.0% | 0.0% | 2,580 | → | 0.0% | 0.0% |
| 2024.09 | 2024/05/13 | Q2予 | 40,000 | → | 0.0% | 0.0% | 4,000 | → | 0.0% | 0.0% | 3,980 | → | 0.0% | 0.0% | 2,580 | → | 0.0% | 0.0% |
| 2024.09 | 2024/02/06 | Q1予 | 40,000 | → | 0.0% | 0.0% | 4,000 | → | 0.0% | 0.0% | 3,980 | → | 0.0% | 0.0% | 2,580 | → | 0.0% | 0.0% |
| 2024.09 | 2023/11/07 | 当初予 | 40,000 | - | - | - | 4,000 | - | - | - | 3,980 | - | - | - | 2,580 | - | - | - |
| 2023.09 | 2023/11/07 | 実 | 37,653 | ↓ | -0.9% | -0.9% | 3,754 | ↑ | +5.4% | +5.4% | 3,721 | ↑ | +7.2% | +7.2% | 2,394 | ↑ | +0.6% | +0.6% |
| 2023.09 | 2023/08/08 | Q3予 | 38,000 | → | 0.0% | 0.0% | 3,560 | → | 0.0% | 0.0% | 3,471 | → | 0.0% | 0.0% | 2,380 | → | 0.0% | 0.0% |
| 2023.09 | 2023/05/09 | Q2予 | 38,000 | → | 0.0% | 0.0% | 3,560 | → | 0.0% | 0.0% | 3,471 | → | 0.0% | 0.0% | 2,380 | → | 0.0% | 0.0% |
| 2023.09 | 2023/02/07 | Q1予 | 38,000 | → | 0.0% | 0.0% | 3,560 | → | 0.0% | 0.0% | 3,471 | → | 0.0% | 0.0% | 2,380 | → | 0.0% | 0.0% |
| 2023.09 | 2022/11/11 | 当初予 | 38,000 | - | - | - | 3,560 | - | - | - | 3,471 | - | - | - | 2,380 | - | - | - |
| 2022.09 | 2022/11/11 | 実 | 36,107 | ↓ | -2.4% | -2.4% | 3,522 | ↑ | +13.8% | +13.8% | 3,487 | ↑ | +15.5% | +15.5% | 2,357 | ↑ | +14.0% | +14.0% |
| 2022.09 | 2022/08/09 | Q3予 | 37,000 | → | 0.0% | 0.0% | 3,095 | → | 0.0% | 0.0% | 3,020 | → | 0.0% | 0.0% | 2,067 | → | 0.0% | 0.0% |
| 2022.09 | 2022/05/09 | Q2予 | 37,000 | → | 0.0% | 0.0% | 3,095 | → | 0.0% | 0.0% | 3,020 | → | 0.0% | 0.0% | 2,067 | → | 0.0% | 0.0% |
| 2022.09 | 2022/02/04 | Q1予 | 37,000 | → | 0.0% | 0.0% | 3,095 | → | 0.0% | 0.0% | 3,020 | → | 0.0% | 0.0% | 2,067 | → | 0.0% | 0.0% |
| 2022.09 | 2021/11/12 | 当初予 | 37,000 | - | - | - | 3,095 | - | - | - | 3,020 | - | - | - | 2,067 | - | - | - |
| 2021.09 | 2021/11/12 | 実 | 33,899 | ↓ | -3.1% | -3.1% | 3,424 | ↓ | -2.2% | -2.2% | 3,414 | ↓ | -1.3% | -1.3% | 2,317 | ↑ | +0.7% | +0.7% |
| 2021.09 | 2021/08/06 | Q3予 | 35,000 | → | 0.0% | 0.0% | 3,500 | → | 0.0% | 0.0% | 3,460 | → | 0.0% | 0.0% | 2,300 | → | 0.0% | 0.0% |
| 2021.09 | 2021/05/12 | Q2予 | 35,000 | → | 0.0% | 0.0% | 3,500 | → | 0.0% | 0.0% | 3,460 | → | 0.0% | 0.0% | 2,300 | → | 0.0% | 0.0% |
| 2021.09 | 2021/02/05 | Q1予 | 35,000 | → | 0.0% | 0.0% | 3,500 | → | 0.0% | 0.0% | 3,460 | → | 0.0% | 0.0% | 2,300 | → | 0.0% | 0.0% |
| 2021.09 | 2020/11/06 | 当初予 | 35,000 | - | - | - | 3,500 | - | - | - | 3,460 | - | - | - | 2,300 | - | - | - |
| 2020.09 | 2020/11/06 | 実 | 33,728 | ↓ | -3.6% | -3.6% | 3,329 | ↑ | +5.7% | +5.7% | 3,295 | ↑ | +5.3% | +5.3% | 2,122 | ↑ | +5.6% | +5.6% |
| 2020.09 | 2020/08/06 | Q3予 | 35,000 | → | 0.0% | 0.0% | 3,150 | → | 0.0% | 0.0% | 3,130 | → | 0.0% | 0.0% | 2,010 | → | 0.0% | 0.0% |
| 2020.09 | 2020/05/13 | Q2予 | 35,000 | → | 0.0% | 0.0% | 3,150 | → | 0.0% | 0.0% | 3,130 | → | 0.0% | 0.0% | 2,010 | → | 0.0% | 0.0% |
| 2020.09 | 2020/02/07 | Q1予 | 35,000 | → | 0.0% | 0.0% | 3,150 | → | 0.0% | 0.0% | 3,130 | → | 0.0% | 0.0% | 2,010 | → | 0.0% | 0.0% |
| 2020.09 | 2019/11/08 | 当初予 | 35,000 | - | - | - | 3,150 | - | - | - | 3,130 | - | - | - | 2,010 | - | - | - |
| 2019.09 | 2019/11/08 | 実 | 33,570 | ↑ | +0.8% | +0.8% | 2,864 | ↑ | +10.2% | +10.2% | 2,828 | ↑ | +8.3% | +8.3% | 1,824 | ↑ | +4.1% | +4.1% |
| 2019.09 | 2019/08/06 | 当初予 | 33,319 | - | - | - | 2,600 | - | - | - | 2,612 | - | - | - | 1,753 | - | - | - |
